Species-specific and age-dependent bile acid composition: aspects on CYP8B and CYP4A subfamilies in bile acid biosynthesis.

Abstract:

:The present review aims to give an overview of the cytochrome P450 8B (CYP8B) and cytochrome P450 4A (CYP4A) subfamilies in relation to biosynthesis of bile acids, in particular trihydroxy bile acids. Trihydroxy bile acids are basically required in most species and have an impact on cholesterol and lipid metabolism. The primary trihydroxy bile acid in most mammals is cholic acid. Some species produce other important trihydroxy bile acids, for example the adult pig which produce hyocholic acid instead of cholic acid. The position of the third hydroxyl group in cholic acid and hyocholic acid, 12alpha or 6alpha position, respectively, has a profound effect on the hydrophilic-hydrophobic property of the trihydroxy bile acids. The CYP8B subfamily is required for introduction of the 12alpha-hydroxyl group in cholic acid biosynthesis. The enzyme responsible for 6alpha-hydroxylation in hyocholic acid biosynthesis, however, varies among species. This review will discuss, in particular, porcine members of the CYP8B and CYP4A subfamilies because interesting findings regarding members of these subfamilies have recently been recognized in this species. CYP8B1 was for a long time believed to be absent in the pig but was recently found to be expressed in fetal pig liver. The enzyme catalyzing the 6alpha-hydroxylation in hyocholic acid biosynthesis in pig was found to be an atypical member of the CYP4A subfamily, denoted CYP4A21. The review presents bile acid biosynthesis in view of these findings and discusses physiochemical properties and developmental-dependent aspects related cholic acid and hyocholic acid biosynthesis.

journal_name

Curr Drug Metab

journal_title

Current drug metabolism

authors

Lundell K,Wikvall K

doi

10.2174/138920008784220574

subject

Has Abstract

pub_date

2008-05-01 00:00:00

pages

323-31

issue

4

eissn

1389-2002

issn

1875-5453

journal_volume

9

pub_type

杂志文章,评审
  • Regulation of sulfotransferases by xenobiotic receptors.

    abstract::The transcription factor networks that regulate basal and xenobiotic-modulated expression of the hepatic sulfotransferases affect the dynamics of xenobiotic detoxication, carcinogen bioactivation and metabolic homeostasis. Emerging evidence suggests that liver-enriched transcription factors, the aryl hydrocarbon (Ah) ...

    journal_title:Current drug metabolism

    pub_type: 杂志文章,评审

    doi:10.2174/1389200054633871

    authors: Runge-Morris M,Kocarek TA

    更新日期:2005-08-01 00:00:00

  • Active metabolites resulting from decarboxylation, reduction and ester hydrolysis of parent drugs.

    abstract::Decarboxylation, reduction and hydrolysis can yield active metabolites from the parent drug. Major therapeutic indications and metabolic routes of these drugs are reviewed. Changes in the logP values (determined and calculated) from the parent drug to the active metabolite show certain characteristics in comparison to...

    journal_title:Current drug metabolism

    pub_type: 杂志文章,评审

    doi:10.2174/138920012800840437

    authors: Hartyánszky I,Kalász H,Adeghate E,Gulyás Z,Hasan MY,Tekes K,Adem A,Sótonyi P

    更新日期:2012-07-01 00:00:00

  • The role of organic ion transporters in drug disposition: an update.

    abstract::Transporters for organic anions and organic cations in kidney, liver, intestine, brain, and placenta play essential roles in drug disposition. The cloning and characterization of these transporters have significantly advanced our understanding of the molecular and cellular mechanisms of the drug disposition process. T...

    journal_title:Current drug metabolism

    pub_type: 杂志文章,评审

    doi:10.2174/1389200043489207

    authors: You G

    更新日期:2004-02-01 00:00:00

  • LC/MS based tools and strategies on qualitative and quantitative analysis of herbal components in complex matrixes.

    abstract::Accompanying with hot discussions on developing multi-target drugs for the therapy of multi-gene diseases, herbal medicines are receiving more and more attention worldwide in both academic and industrial fields. Pharmacokinetic and metabolic research is one of the important issues for intensive understanding of therap...

    journal_title:Current drug metabolism

    pub_type: 杂志文章,评审

    doi:10.2174/138920012803341285

    authors: Wu L,Hao H,Wang G

    更新日期:2012-11-01 00:00:00

  • Characterization of drug interactions with serum proteins by using high-performance affinity chromatography.

    abstract::The binding of drugs with serum proteins can affect the activity, distribution, rate of excretion, and toxicity of pharmaceutical agents in the body. One tool that can be used to quickly analyze and characterize these interactions is high-performance affinity chromatography (HPAC). This review shows how HPAC can be us...

    journal_title:Current drug metabolism

    pub_type: 杂志文章,评审

    doi:10.2174/138920011795202938

    authors: Hage DS,Anguizola J,Barnaby O,Jackson A,Yoo MJ,Papastavros E,Pfaunmiller E,Sobansky M,Tong Z

    更新日期:2011-05-01 00:00:00

  • Precision-cut organ slices as a tool to study toxicity and metabolism of xenobiotics with special reference to non-hepatic tissues.

    abstract::Metabolism of xenobiotics is often seen as an exclusive function of the liver, but some current findings support the notion that the lungs, kidneys and intestine may contribute considerably. After the establishment of the use of liver slices as a useful in vitro model to study metabolism and toxicity of xenobiotics, t...

    journal_title:Current drug metabolism

    pub_type: 杂志文章,评审

    doi:10.2174/1389200023338071

    authors: de Kanter R,Monshouwer M,Meijer DK,Groothuis GM

    更新日期:2002-02-01 00:00:00

  • Toxicogenomics.

    abstract::Toxicogenomics is defined as an integration of genomics (transcriptomics, proteomics and metabolomics) and toxicology. It is a scientific field that studies how the genome is involved in responses to environmental stressors and toxicants. It combines studies of mRNA expression, cell and tissue-wide protein expression ...

    journal_title:Current drug metabolism

    pub_type: 杂志文章,评审

    doi:10.2174/138920008783884696

    authors: Gomase VS,Tagore S

    更新日期:2008-03-01 00:00:00

  • Oral L-carnitine: metabolite formation and hemodialysis.

    abstract::L-Carnitine has important roles in intermediary metabolism and patients with end-stage renal disease who are undergoing hemodialysis may develop a secondary L-carnitine deficiency. The extent of accumulation of the metabolites trimethylamine and trimethylamine-N-oxide when L-carnitine is administered orally has not be...

    journal_title:Current drug metabolism

    pub_type: 临床试验,杂志文章

    doi:10.2174/138920006778520561

    authors: Bain MA,Faull R,Milne RW,Evans AM

    更新日期:2006-10-01 00:00:00

  • Total Sleep Duration and Risk of Type 2 Diabetes: Evidence-Based On Clinical and Epidemiological Studies.

    abstract:BACKGROUND:Increasing incidences of type 2 diabetes make it necessary to have a better understanding of the risk factors for its prediction. Taking a note of resilience in risk factors, dynamics of the emerging factors other than traditional ones are showing a great interest in recent years which imprints a significant...

    journal_title:Current drug metabolism

    pub_type: 杂志文章,评审

    doi:10.2174/1389200219666180628170431

    authors: Yadav D,Cho KH

    更新日期:2018-01-01 00:00:00

  • New insights into the structural features and functional relevance of human cytochrome P450 2C9. Part II.

    abstract::Part I of this article published in the previous issue of Current Drug Metabolism discussed the substrate specificity, inhibitor selectivity and structure-activity relationship (SAR) of human CYP2C9. The features of CYP2C9 pharmacophore and SAR models have been elaborated. Part II of this article will address the homo...

    journal_title:Current drug metabolism

    pub_type: 杂志文章,评审

    doi:10.2174/138920009790820101

    authors: Mo SL,Zhou ZW,Yang LP,Wei MQ,Zhou SF

    更新日期:2009-12-01 00:00:00

  • Nanotechnologies: a strategy to overcome blood-brain barrier.

    abstract::The possibility to treat central nervous system (CNS) disorders is strongly limited by the poor access of many therapeutic agent to the target tissues. This is mainly due to the presence of the blood-brain barrier (BBB), formed by a complex interplay of endothelial cells, astrocyte and pericytes, through which only se...

    journal_title:Current drug metabolism

    pub_type: 杂志文章,评审

    doi:10.2174/138920012798356943

    authors: De Rosa G,Salzano G,Caraglia M,Abbruzzese A

    更新日期:2012-01-01 00:00:00

  • Interplay of metabolism and transport in determining oral drug absorption and gut wall metabolism: a simulation assessment using the "Advanced Dissolution, Absorption, Metabolism (ADAM)" model.

    abstract::Bioavailability of orally administered drugs can be influenced by a number of factors including release from the formulation, dissolution, stability in the gastrointestinal (GI) environment, permeability through the gut wall and first-pass gut wall and hepatic metabolism. Although there are various enzymes in the gut ...

    journal_title:Current drug metabolism

    pub_type: 杂志文章

    doi:10.2174/138920010794328913

    authors: Darwich AS,Neuhoff S,Jamei M,Rostami-Hodjegan A

    更新日期:2010-11-01 00:00:00

  • Changes of Transporters and Drug-metabolizing Enzymes in Nephrotic Syndrome.

    abstract:BACKGROUND:Drug-metabolizing enzymes and transporters play key roles in drug disposition and drug interactions. The alterations of their expression will influence drug pharmacokinetics and pharmacodynamics. However, the changes in the expression of enzymes and transporters in the disease state are still unclear. OBJEC...

    journal_title:Current drug metabolism

    pub_type: 杂志文章

    doi:10.2174/1389200221666200512113731

    authors: Dong Y,Gong L,Lu X,Ye M,Lin Y,Xie S,Zhang J,Zhou F,Tang L,Zou W,Liu M

    更新日期:2020-01-01 00:00:00

  • Pharmacokinetic and metabolism determinants of fluoropyrimidines and oxaliplatin activity in treatment of colorectal patients.

    abstract::Fluoropyrimidines and oxaliplatin continued to be the mainstay of therapeutic regimens in the treatment of colorectal cancer (CRC). For this reason, pharmacokinetic and metabolism of these drugs were analyzed and the identification of accurate and validated predictive, prognostic and toxicity markers became necessary ...

    journal_title:Current drug metabolism

    pub_type: 杂志文章,评审

    doi:10.2174/138920011798062300

    authors: Gnoni A,Russo A,Silvestris N,Maiello E,Vacca A,Marech I,Numico G,Paradiso A,Lorusso V,Azzariti A

    更新日期:2011-12-01 00:00:00

  • Emerging technologies, recent developments, and novel applications for drug metabolite identification.

    abstract::Drug metabolite identification and metabolic characteristics analysis play a crucial role in new drug research and development, because they can lead to varied efficacy, severe adverse reactions, and even toxicity. Classical methodologies for metabolite identification have mainly been based on mass spectrometry (MS) c...

    journal_title:Current drug metabolism

    pub_type: 杂志文章,评审

    doi:10.2174/1389200216666141230105649

    authors: Lu W,Xu Y,Zhao Y,Cen X

    更新日期:2014-01-01 00:00:00

  • N-dealkylation of arylpiperazine derivatives: disposition and metabolism of the 1-aryl-piperazines formed.

    abstract::In recent years several arylpiperazine derivatives have reached the stage of clinical application, mainly for the treatment of depression, psychosis or anxiety. Examples are the pyrimidinylpiperazine buspirone, the chlorophenylpiperazine derivatives nefazodone and trazodone, the dichlorophenylpiperazine aripiprazole a...

    journal_title:Current drug metabolism

    pub_type: 杂志文章,评审

    doi:10.2174/138920007781368908

    authors: Caccia S

    更新日期:2007-08-01 00:00:00

  • Psychedelic 5-methoxy-N,N-dimethyltryptamine: metabolism, pharmacokinetics, drug interactions, and pharmacological actions.

    abstract::5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) belongs to a group of naturally-occurring psychoactive indolealkylamine drugs. It acts as a nonselective serotonin (5-HT) agonist and causes many physiological and behavioral changes. 5-MeO-DMT is O-demethylated by polymorphic cytochrome P450 2D6 (CYP2D6) to an active metab...

    journal_title:Current drug metabolism

    pub_type: 杂志文章,评审

    doi:10.2174/138920010794233495

    authors: Shen HW,Jiang XL,Winter JC,Yu AM

    更新日期:2010-10-01 00:00:00

  • Nanotechology-based strategies to enhance the efficacy of photodynamic therapy for cancers.

    abstract::Photodynamic therapy (PDT) combines photosensitizer, visible light and oxygen, which has the characteristics of high selectivity, minimal invasiveness, low side effect, and allowing repetitive application. The photophysics and mechanisms leading to cell death mediated by PDT have been studied extensively, and PDT has ...

    journal_title:Current drug metabolism

    pub_type: 杂志文章

    doi:10.2174/138920009790274559

    authors: Li WT

    更新日期:2009-10-01 00:00:00

  • Effects of Montmorillonite on Growth Performance, Serum Biochemistry and Oxidative Stress of Red-Crowned Crane (Grus japonensis) Fed Mycotoxin-Contaminated Feed.

    abstract:BACKGROUND:The red-crowned crane (Grus japonensis) is one of the most vulnerable bird species in the world. Mycotoxins are toxic secondary metabolites produced by fungi and considered naturally unavoidable contaminants in animal feed. Our recent survey indicated that the mycotoxins had the potential to contaminate redc...

    journal_title:Current drug metabolism

    pub_type: 杂志文章

    doi:10.2174/1389200221666200726221126

    authors: Liu D,Wu Q,Liu H,Lu C,Gu C,Kuca K,Wu W

    更新日期:2020-01-01 00:00:00

  • Drug-induced Cholestasis: Mechanisms, Models, and Markers.

    abstract:BACKGROUND:Drug-induced cholestasis is a risk factor in the progression of drug candidates, and poses a serious health hazard if not detected before going into a human. Intrahepatic accumulation of Bile Acids (BAs) represents a characteristic phenomenon associated with drug-induced cholestasis. METHODS:This review wil...

    journal_title:Current drug metabolism

    pub_type: 杂志文章,评审

    doi:10.2174/1389200219666180427165035

    authors: Chatterjee S,Annaert P

    更新日期:2018-01-01 00:00:00

  • Physiologically Based In vitro Models to Predict the Oral Dissolution and Absorption of a Solid Drug Delivery System.

    abstract::To understand the sophisticated dynamic behaviors of drug elution and permeation in the gastrointestinal tract (GIT), researchers have tried to reemerge it by employing various in vitro experimental models. However, official in vitro apparatuses routinely used for quality control purposes, employ simple, non-physiolog...

    journal_title:Current drug metabolism

    pub_type: 杂志文章,评审

    doi:10.2174/1389200216666150812123836

    authors: Li Z,He X

    更新日期:2015-01-01 00:00:00

  • Metabolism of designer drugs of abuse: an updated review.

    abstract::This paper reviews the metabolism of new designer drugs of abuse that have emerged on the black market during the last years and is an update of a review published in 2005. The presented review contains data concerning the so-called 2C compounds (phenethylamine type) such as 4-bromo-2,5-dimethoxy-beta-phenethylamine (...

    journal_title:Current drug metabolism

    pub_type: 杂志文章,评审

    doi:10.2174/138920010791526042

    authors: Meyer MR,Maurer HH

    更新日期:2010-06-01 00:00:00

  • Age-related changes in pharmacokinetics.

    abstract::Ageing is characterized by a progressive decline in the functional reserve of multiple organs and systems, which can influence drug disposition. In addition, comorbidity and polypharmacy are highly prevalent in the elderly. As ageing is associated with some reduction in first-pass metabolism, bioavailability of a few ...

    journal_title:Current drug metabolism

    pub_type: 杂志文章,评审

    doi:10.2174/138920011796504527

    authors: Shi S,Klotz U

    更新日期:2011-09-01 00:00:00

  • The role of mass spectrometry in biomarker discovery and measurement.

    abstract::Recent advances in the biological and analytical sciences have led to unprecedented interest in the discovery and quantitation of endogenous molecules that serve as indicators of drug safety, mechanism of action, efficacy, and disease state progression. By allowing for improved decision-making, these indicators, refer...

    journal_title:Current drug metabolism

    pub_type: 杂志文章,评审

    doi:10.2174/138920006777697918

    authors: Ackermann BL,Hale JE,Duffin KL

    更新日期:2006-06-01 00:00:00

  • Talin: A Potential Drug Target for Cancer Therapy.

    abstract::Talin is an intracellular cytoskeletal protein and one of the major components of the focal adhesion complex. It mainly acts as an interlink between transmembrane integrin receptors and cytosolic F-actin. Apart from integrins and actin, it also interacts with various other proteins in the adhesion complex to regulate ...

    journal_title:Current drug metabolism

    pub_type: 杂志文章

    doi:10.2174/1389200221666200214114018

    authors: Malla RR,Vempati RK

    更新日期:2020-01-01 00:00:00

  • A Review of Theranostics Applications and Toxicities of Carbon Nanomaterials.

    abstract:BACKGROUND:In the last few years, the use of modified Carbon Nanomaterials (CNMs) for theranostics (therapeutic and diagnosis) applications is a new and rapidly growing area in pharmacy and medical fields. Owing to this, their specific physicochemical behaviors like high stability, drug loading, surface area to volume ...

    journal_title:Current drug metabolism

    pub_type: 杂志文章,评审

    doi:10.2174/1389200219666180925094515

    authors: Gupta N,Rai DB,Jangid AK,Kulhari H

    更新日期:2019-01-01 00:00:00

  • Nanotechnology-based Drug Delivery, Metabolism and Toxicity.

    abstract:BACKGROUND:Nanoparticles (NPs) are being used extensively owing to their increased surface area, targeted delivery and enhanced retention. NPs have the potential to be used in many disease conditions. Despite widespread use, their toxicity and clinical safety still remain a major concern. OBJECTIVE:The purpose of this...

    journal_title:Current drug metabolism

    pub_type: 杂志文章,评审

    doi:10.2174/1389200221666200103091753

    authors: Malaviya P,Shukal D,Vasavada AR

    更新日期:2019-01-01 00:00:00

  • Physiologically-Based Pharmacokinetic (PBPK) Modelling of Transporter Mediated Drug Absorption, Clearance and Drug-Drug Interactions.

    abstract::Membrane transporters play an important role in intestinal absorption, distribution and clearance of drugs. Additionally transporters along with enzymes regulate tissue exposures (e.g. liver, kidney and brain), which are important for safety and efficacy considerations. Early identification of transporters involved gu...

    journal_title:Current drug metabolism

    pub_type: 杂志文章

    doi:10.2174/1389200221999210101233340

    authors: Taskar KS,Harada I,Alluri RV

    更新日期:2021-01-01 00:00:00

  • Intestinal absorption and presystemic elimination of various chemical constituents present in GBE50 extract, a standardized extract of Ginkgo biloba leaves.

    abstract::The nature and level of systemic exposure to the active herbal constituents will profoundly affect their effects at action sites, which is fundamental in understanding their roles in the overall beneficial effects of a herbal medicine. The objective of this study is to gain a full picture of the systemic exposure to v...

    journal_title:Current drug metabolism

    pub_type: 杂志文章

    doi:10.2174/1389200211209050494

    authors: Li L,Zhao Y,Du F,Yang J,Xu F,Niu W,Ren Y,Li C

    更新日期:2012-06-01 00:00:00

  • Impact of various factors on pharmacokinetics of bioactive polyphenols: an overview.

    abstract::Several epidemiological studies throughout the years have suggested that polyphenols from fruits and vegetables promote health and reduce the risk of certain chronic and neurodegenerative diseases. Yet, it has been proved to be extremely difficult to quantitatively establish the benefit afforded by polyphenols, princi...

    journal_title:Current drug metabolism

    pub_type: 杂志文章,评审

    doi:10.2174/1389200214666131210144115

    authors: Rubió L,Macià A,Motilva MJ

    更新日期:2014-01-01 00:00:00